Dementias Completed Phase 3 Trials for Rivastigmine (DB00989)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02035982Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's DiseaseTreatment